1. Home
  2. PGEN vs ATLC Comparison

PGEN vs ATLC Comparison

Compare PGEN & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.81

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Atlanticus Holdings Corporation

ATLC

Atlanticus Holdings Corporation

HOLD

Current Price

$76.33

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
ATLC
Founded
1998
1996
Country
United States
United States
Employees
N/A
576
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PGEN
ATLC
Price
$3.81
$76.33
Analyst Decision
Buy
Strong Buy
Analyst Count
5
7
Target Price
$8.33
$90.00
AVG Volume (30 Days)
4.0M
79.3K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$477.21
Revenue Next Year
$81.04
$10.42
P/E Ratio
N/A
$9.74
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$45.74
52 Week High
$5.47
$93.21

Technical Indicators

Market Signals
Indicator
PGEN
ATLC
Relative Strength Index (RSI) 38.10 46.45
Support Level $3.49 $51.15
Resistance Level $4.40 $79.60
Average True Range (ATR) 0.29 4.15
MACD -0.07 -0.89
Stochastic Oscillator 2.97 4.50

Price Performance

Historical Comparison
PGEN
ATLC

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

Share on Social Networks: